Skip to content
Marlbridge

Practice Questions

AQA A-level Biology: Cell Recognition and the Immune System (7402) – Practice Questions

Original questions with worked answers on AQA A-level Biology 3.2.4: antigens, phagocytosis, T and B cells, antibodies, vaccines, HIV, monoclonals and ELISA.

Subject
Biology
Level
A LEVEL (AS CONTENT)
Topic
Cell Recognition and the Immune System
Updated

Aligned to AQA A Level Biology (7402), For first teaching 2015. Official specification .

Syllabus page (what it covers and how it is assessed): AQA A Level Biology.

Syllabus points this page covers

7402 (AS content of the A Level)

  • 3.2.4 Cell recognition and the immune system

Found an error? Report a correction.

Need help with this topic? Request a free trial class for A Level Biology (7402).

These are original questions written for Marlbridge, for revision and practice on this content. They are not reproduced past-paper questions, and they do not replicate the exam’s exact structure, question count or mark tariffs – examination boards hold copyright in their own papers. Use these alongside the official past papers from your board or school.

These questions are aligned to section 3.2.4, Cell recognition and the immune system, in the AQA AS and A-level Biology specification (A-level 7402), for first teaching 2015, exams June 2016 onwards. The section is AS content. Questions 9 and 10 ask you to evaluate data, as the specification requires for vaccines and monoclonal antibodies. Every answer gives the marking points.

Related: Cell recognition and the immune system study guide and revision notes. Course hub: AQA A-level Biology.

How should you use these questions?

Write full answers, then mark them. Use the specification’s terms: antigen-presenting cell, helper T cell, clonal selection, plasma cell, memory cell, complementary.

Questions

1. Define the term antigen. [1]

2. Give four types of cell or substance that the immune system can identify from the molecules on their surfaces. [2]

3. Describe how a phagocyte destroys a bacterium. [4]

4. Describe the role of helper T cells in the immune response. [3]

5. Describe the humoral response to a bacterium entering the body for the first time. [5]

6.

(a) Describe the structure of an antibody. [3] (b) Explain why an antibody binds to only one type of antigen. [2] (c) Explain how antibodies lead to the destruction of bacteria. [2]

7. A person is infected with the same strain of a virus twice, two years apart. Explain why they show symptoms after the first infection but not after the second. [3]

8. Explain why a new influenza vaccine is developed most years. [2]

9. In a vaccine trial, 12 000 volunteers received the vaccine and 12 000 received a placebo. Over one year, 18 vaccinated volunteers and 162 placebo volunteers caught the disease.

(a) Calculate the percentage of each group that caught the disease. [2] (b) Calculate the percentage reduction in cases in the vaccinated group compared with the placebo group. [1] (c) Explain why a placebo group was used. [1] (d) Give two other features of the trial that would make the result more reliable. [2]

10. A baby is protected from some diseases for a few months by antibodies from breast milk. A vaccinated adult is protected for many years. Explain the difference. [3]

11. Explain how herd immunity protects a person who cannot be vaccinated. [2]

12. Describe how HIV replicates inside a helper T cell. [4]

13. Explain why a person with AIDS may die from a disease that a healthy person would survive. [3]

14. Explain why antibiotics cannot be used to treat HIV infection. [2]

15. Describe how a monoclonal antibody can be used to target a drug to cancer cells. [2]

16. In an ELISA test for antibodies to a virus, explain:

(a) why the well is washed after the patient’s sample is added and again after the enzyme-linked antibody is added; [2] (b) why a control well containing no antigen is used. [1]

17. Discuss two ethical issues associated with the use of vaccines. [2]

Answers

1. A (foreign) molecule, usually a protein, that triggers an immune response by lymphocytes [1].

2. All four for 2 marks, two or three for 1 mark: pathogens; cells from other organisms of the same species; abnormal body cells; toxins.

3. The phagocyte recognises the bacterium’s antigens and engulfs it [1], enclosing it in a phagosome [1]; a lysosome fuses with the phagosome [1]; lysozymes hydrolyse / digest the bacterium [1]. (Also credit: antigens presented on the phagocyte surface.)

4. A helper T cell with a complementary receptor binds to an antigen on an antigen-presenting cell and divides by mitosis [1]. It stimulates cytotoxic T cells to kill infected cells [1], and stimulates B cells to divide and phagocytes to engulf pathogens [1].

5. Any five [1 each]: a B cell with a complementary antibody receptor binds the antigen; the B cell takes in and presents the antigen; a helper T cell activates the B cell; clonal selection; the B cell divides by mitosis; forming plasma cells that secrete antibodies; and memory cells; antibodies bind antigens, forming antigen-antibody complexes.

6. (a) Four polypeptide chains: two heavy and two light [1], joined by disulfide bridges [1]; variable regions with antigen-binding sites and a constant region (and hinge region) [1]. (b) The variable region has a specific amino acid sequence, so a specific tertiary structure / shape of binding site [1], which is complementary to only one antigen [1]. (c) Antibodies have two binding sites, so they cause agglutination / clump bacteria together [1]; phagocytes then engulf and destroy the clumps [1].

7. First infection: primary response is slow because there are few B and T cells with complementary receptors, so the virus replicates and causes symptoms [1]. Memory cells were made [1]. Second infection: memory cells divide rapidly into plasma cells, making antibodies quickly and in larger amounts, so the virus is destroyed before symptoms appear [1].

8. The influenza virus shows antigen variability / its antigens change (by mutation) [1], so memory cells from the previous vaccine are not complementary to the new antigens [1].

9. (a) Vaccinated: 18 / 12 000 x 100 = 0.15% [1]. Placebo: 162 / 12 000 x 100 = 1.35% [1]. (b) (1.35 - 0.15) / 1.35 x 100 = 88.9% reduction (89%) [1]. (c) To show whether the vaccine, not other factors (such as the injection or belief in treatment), caused the difference / to give a comparison [1]. (d) Any two [1 each]: double-blind design; random allocation to groups; groups matched for age, sex, health; volunteers from different populations / several trials; followed up for longer.

10. Breast milk gives passive immunity: antibodies come from the mother [1]; no memory cells are made, and the antibodies are broken down, so protection is short-term [1]. Vaccination gives active immunity, with memory cells produced, so protection lasts years [1].

11. Most people in the population are immune, so the pathogen cannot pass easily between people [1]; the unvaccinated person is less likely to meet an infected person [1].

12. Attachment protein binds to a receptor on the helper T cell [1]; the capsid releases RNA (and enzymes) into the cell [1]; reverse transcriptase makes DNA from the viral RNA [1]; the DNA is inserted into the host DNA and used to make new viral proteins and RNA, assembled into new HIV particles [1].

13. HIV destroys helper T cells [1], so B cells and cytotoxic T cells are not stimulated / the immune response is weak [1]; opportunistic infections cannot be fought off [1].

14. Antibiotics act on bacterial structures (such as murein cell walls) or bacterial processes, which viruses do not have [1]; HIV uses the host cell’s enzymes and ribosomes to replicate, so there is no viral target for the antibiotic [1].

15. The drug is attached to a monoclonal antibody complementary to an antigen found only on cancer cells [1]; the antibody binds those cells, so the drug acts on them and fewer normal cells are harmed [1].

16. (a) First wash removes antibodies that have not bound to the antigen [1]; second wash removes unbound enzyme-linked antibody, which would change the substrate’s colour and give a false positive [1]. (b) To show that colour only develops when the antigen is present / that the antibodies do not bind to the well itself [1].

17. Any two [1 each]: use of animals in development and testing; side effects / risk to volunteers in trials; whether vaccination should be compulsory (individual choice against herd immunity); fair access and cost in poorer countries.

Where marks are usually lost

  • Writing “lysosomes digest the bacterium” without naming lysozymes.
  • Saying T cells produce antibodies.
  • Describing antigens and antibodies as the same shape instead of complementary.
  • Forgetting to mention memory cells in the secondary response.
  • Using the wrong denominator in a percentage reduction.

Frequently asked questions

Which cells produce antibodies? Plasma cells, which form when activated B cells divide.

Do I need to know how monoclonal antibodies are made? No. AQA states that details of the commercial or scientific production of monoclonal antibodies are not required.

How detailed should HIV structure be? Know RNA, reverse transcriptase, capsid, lipid envelope and attachment proteins, and how the virus replicates in helper T cells.

Official syllabus

AQA AS and A-level Biology (7401/7402) specification, Version 1.5, section 3.2.4 Cell recognition and the immune system.

Get free revision emails (optional)

Occasional emails with practice questions, worked explanations and links to free resources for the qualification and subjects you choose. No spam, and you can unsubscribe from any email. The free tools on this site never need an email.

Subjects (optional, up to 6)

Choose a qualification to see its subjects.

Related resources

Related articles

Studying this with a teacher

Working through Biology A LEVEL (AS CONTENT)?

This page is free and stays free. If you would rather be taught it, Marlbridge runs Biology classes one-to-one and in small groups of up to 15, online in your own time zone. The first trial class is free. WhatsApp replies within an hour (8am–11pm Pakistan time, every day); email the same day.